{"id":1920,"date":"2025-11-22T07:00:09","date_gmt":"2025-11-22T07:00:09","guid":{"rendered":"https:\/\/www.ynzgroup.co.in\/blog\/?post_type=wednesday_wisdom&#038;p=1920"},"modified":"2026-11-05T07:35:58","modified_gmt":"2026-11-05T07:35:58","slug":"a-bitter-dose-for-pharma-compliance","status":"publish","type":"wednesday_wisdom","link":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/","title":{"rendered":"A Bitter Dose for Pharma Compliance"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\" style=\"margin-top:30px\">Introduction[1]:<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">India, now also referred to as the \u201cPharmacy of the World,\u201d has emerged as a global pharmaceutical powerhouse supplying to global vaccine demand and exporting affordable generic medicines to several countries. With an industry valued at over USD 49.78 billion in 2023[2], India\u2019s drug manufacturing ecosystem has become eminent to both domestic healthcare and international markets that rely on its low-cost\/cost-effective, high-quality generics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, this position of strength also carries a great responsibility to uphold high quality control in manufacturing and testing, ensuring patient safety, and maintaining global trust in Indian medicines. The recent tragedy in Madhya Pradesh, where 24 children lost their lives after consuming a cough syrup \u2018Coldrif\u2019, prescribed by local doctor Praveen Soni serves as a significant reminder of what happens when pharmaceutical ethics and regulatory vigilance are overlooked. This article examines the key legal breaches involved, the liabilities arising from it, and the larger compliance failures that caused this tragedy.<\/p>\n\n\n\n<h5 class=\"wp-block-heading has-black-color has-text-color has-link-color wp-elements-1\">The toxic ingredient<\/h5>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-2 wp-block-paragraph\">Reports suggest that a paediatrician\u00a0 doctor\u00a0 Praveen Soni\u00a0 prescribed\u00a0 Coldrif cough syrup to several of his children patients. The manufacturing pharma company Sresan Pharmaceuticals Limited sourced industrial grade propylene glycol from local chemical traders and paint dealers, rather than certified pharmaceutical suppliers. Such cheaper industrial grade chemicals are commonly contaminated with toxic ethylene glycol and diethylene glycol. The syrup contained Diethylene Glycol (DEG) a chemical used in industrial solvent which led to difficulty in passing urine and acute kidney failure among the victims. Upon lab testing, Coldrif batch was found to contain over 48.6% DEG[3] which is nearly 500 times the permissible limit.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This tragedy has led to questions about the compliance culture within India\u2019s drug manufacturing sector under the Drugs and Cosmetics Act, 1940. However, who will restore the joy of those unfortunate families who lost their children due to this negligence?<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Layers of Accountability<\/h5>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Under the Drugs and Cosmetics Act, 1940:<\/strong> The lapses herein primarily fall under the ambit of The drugs and cosmetics Act 1940. This Act governs manufacture, sale, and distribution of drugs and Section18(a)(i) prohibits any person from manufacturing or selling a drug that is not of standard quality or is adulterated or spurious. Breach of this provision attracts legal consequences under Section 27(a) of severe imprisonment of not less than 10 years, which may extend to life and shall also be liable to fine which shall not be less than ten lakh rupees or three times value of the drugs confiscated, whichever is more.<\/li>\n\n\n\n<li><strong>Manufacturing Non-Compliance and GMP Violations:<\/strong><br><strong>Under the Drugs and Cosmetics Rules, 1945<\/strong>[4], Rule 71 contains conditions for\u00a0grant\u00a0and\u00a0\u00a0\u00a0 renewal\u00a0of\u00a0license.\u00a0Rule\u00a071 (7)\u00a0states that every licensed manufacturer must\u00a0adhere to Good\u00a0\u00a0\u00a0\u00a0\u00a0 Manufacturing\u00a0 Practices (GMP) prescribed in Schedule M. These include strict protocols for:\n<ul class=\"wp-block-list\">\n<li><strong>Sanitation:<\/strong> The manufacturing premises shall be cleaned and maintained in an orderly manner, so that it is free from accumulated waste, dust, debris and other similar material.<\/li>\n\n\n\n<li><strong>Source of Raw Material:<\/strong> All incoming materials shall be purchased from approved sources under valid purchase vouchers. Wherever possible, raw materials should be purchased directly from the producers.<\/li>\n\n\n\n<li><strong>Testing and Quality control systems :<\/strong>Quality control shall be concerned with sampling, specifications, testing, documentation, release procedures which ensure that the necessary and relevant tests are actually carried and that the materials are not released for use, nor products released for sale or supply until their quality has been judged to be satisfactory. It is not confined to laboratory operations but shall be involved in all decisions concerning the quality of the product.<\/li>\n\n\n\n<li><strong>Quality Control Area:<\/strong> Schedule M, Part I requires quality control laboratories to be independent of the production areas. The head of the quality control laboratory shall be independent of the manufacturing unit and the testing shall be conducted under the direct supervision of competent technical staff.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ingredients and quantity under Rule 71(6)(iv)<\/strong>[5] the proprietary medicine shall contain such ingredients and in such quantities for which there is therapeutic justification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under Rule 74(c) each batch of raw material as well as finished products must be verified for purity and quality before use.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A prominent default was that the company procured and used industrial-grade solvents and excipients instead of pharmaceutical-grade material which is a direct violation of GMP. Such failure points to gross negligence or wilful disregard of the manufacturer\u2019s statutory obligations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Apart from this, the drug inspector stated in their report that medicines in the unit were stored under unhygienic conditions. There was no pest control measures, purified water generation system or cleaning procedures in place. Equipment in the unit was rusty cracked and leaking.[6]<\/p>\n\n\n\n<h5 class=\"wp-block-heading has-black-color has-text-color has-link-color wp-elements-3\">Conclusion:<\/h5>\n\n\n\n<p class=\"wp-block-paragraph\">This tragedy in Madhya Pradesh serves as a stark reminder of the critical role that legal compliance and quality control play in safeguarding public health. India\u2019s pharmaceutical sector, while globally respected, must continuously strengthen its internal checks, GMP adherence, and regulatory coordination under the Drugs and Cosmetics Act, 1940. Consistent inspections, transparent reporting, and ethical manufacturing practices are very important to preventing lapses and preserving global confidence in Indian medicines.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<ol style=\"margin-top:30px\" class=\"wp-block-list\">\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-4\">The article reflects the general work of the authors and the views expressed are personal. No reader should act on any statement contained herein without seeking detailed professional advice.<\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-5\"><a href=\"https:\/\/ibef.org\/exports\/pharmaceutical-exports-from-india\">https:\/\/ibef.org\/exports\/pharmaceutical-exports-from-india<\/a><\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-6\"><a href=\"https:\/\/timesofindia.indiatimes.com\/city\/chennai\/tn-drug-inspectors-had-failed-to-detect-toxic-cough-syrup-production-for-14-years\/articleshow\/124370194.cms\">https:\/\/timesofindia.indiatimes.com\/city\/chennai\/tn-drug-inspectors-had-failed-to-detect-toxic-cough-syrup-production-for-14-years\/articleshow\/124370194.cms<\/a><\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-7\"><a href=\"https:\/\/www.indiacode.nic.in\/bitstream\/123456789\/15278\/1\/drug_cosmeticsa1940-23.pdf\">https:\/\/www.indiacode.nic.in\/bitstream\/123456789\/15278\/1\/drug_cosmeticsa1940-23.pdf<\/a><\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-8\"><a href=\"https:\/\/cdsco.gov.in\/opencms\/export\/sites\/CDSCO_WEB\/Pdfdocuments\/acts_rules\/2016DrugsandCosmeticsAct1940Rules1945.pdf\"><u>https:\/\/cdsco.gov.in\/opencms\/export\/sites\/CDSCO_WEB\/Pdfdocuments\/acts_rules\/2016DrugsandCosmeticsAct1940Rules1945.pdf<\/u><\/a>\u00a0\u00a0\u00a0 <\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-9\"><a href=\"https:\/\/timesofindia.indiatimes.com\/city\/chennai\/tn-drug-inspectors-had-failed-to-detect-toxic-cough-syrup-production-for-14-years\/articleshow\/124370194.cms\"><u>https:\/\/timesofindia.indiatimes.com\/city\/chennai\/tn-drug-inspectors-had-failed-to-detect-toxic-cough-syrup-production-for-14-<\/u>y<u>ears\/articleshow\/124370194.cms<\/u><\/a><\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-10\"><a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadPublic_NoticesFiles\/FDCpublic18dec23.pdf\"><u>https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadPublic_NoticesFiles\/FDCpublic18dec23.pdf<\/u><\/a><\/li>\n\n\n\n<li class=\"has-black-color has-text-color has-link-color has-small-font-size wp-elements-11\"><a href=\"https:\/\/www.who.int\/news\/item\/13-10-2025-medical-product-alert-n-5-2025--substandard-(contaminated)-oral-liquid-medicines\"><u>Medical Product Alert N\u00b05\/2025: Substandard<\/u> (<u>contaminated<\/u>) <u>oral liquid medicines<\/u><\/a><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-12 wp-block-paragraph\">For any feedback or response on this article, the authors can be reached on <a href=\"mailto:kedar.gurjar@ynzgroup.co.in\">kedar.gurjar@ynzgroup.co.in<\/a> and <a href=\"mailto:ankita.doke@ynzgroup.co.in\">ankita.doke@ynzgroup.co.in<\/a><\/p>\n\n\n\n<div class=\"wp-block-columns has-background is-layout-flex wp-container-core-columns-is-layout-4daffda4 wp-block-columns-is-layout-flex\" style=\"background-color:#ededed;padding-top:10px;padding-right:10px;padding-bottom:10px;padding-left:10px\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:15%\">\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"200\" height=\"200\" src=\"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/02\/articles-kedar-gurjar.jpg\" alt=\"\" class=\"wp-image-474\" srcset=\"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/02\/articles-kedar-gurjar.jpg 200w, https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/02\/articles-kedar-gurjar-150x150.jpg 150w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80%\">\n<p class=\"has-black-color has-text-color has-link-color wp-elements-13 wp-block-paragraph\"><strong>Author : Kedar Gurjar<\/strong><br>Kedar is an Associate at YNZ Legal. By qualification he is Bachelor of Commerce and Bachelor of Law from G.J. Advani Law college, Bandra, Mumbai University.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns has-background is-layout-flex wp-container-core-columns-is-layout-4daffda4 wp-block-columns-is-layout-flex\" style=\"background-color:#ededed;padding-top:10px;padding-right:10px;padding-bottom:10px;padding-left:10px\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:15%\">\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"200\" height=\"200\" src=\"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/10\/articles-ankita-doke.jpg\" alt=\"\" class=\"wp-image-1104\" srcset=\"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/10\/articles-ankita-doke.jpg 200w, https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2024\/10\/articles-ankita-doke-150x150.jpg 150w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:80%\">\n<p class=\"has-black-color has-text-color has-link-color wp-elements-14 wp-block-paragraph\"><strong>Co-Author : Ankita Doke<\/strong><br>Ankita is an Associate at YNZ Legal. By qualification she is Bachelor of Law from Pune University<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Introduction[1]: India, now also referred to as the \u201cPharmacy of the World,\u201d has emerged as a global pharmaceutical powerhouse supplying to global vaccine demand and exporting affordable generic medicines to several countries. With an industry valued at over USD 49.78 billion in 2023[2], India\u2019s drug manufacturing ecosystem has become eminent to both domestic healthcare and [&hellip;]<\/p>\n","protected":false},"featured_media":1922,"template":"","practice_area":[15],"class_list":["post-1920","wednesday_wisdom","type-wednesday_wisdom","status-publish","has-post-thumbnail","hentry","practice_area-other"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Bitter Dose for Pharma Compliance - YNZ Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Bitter Dose for Pharma Compliance - YNZ Group\" \/>\n<meta property=\"og:description\" content=\"Introduction[1]: India, now also referred to as the \u201cPharmacy of the World,\u201d has emerged as a global pharmaceutical powerhouse supplying to global vaccine demand and exporting affordable generic medicines to several countries. With an industry valued at over USD 49.78 billion in 2023[2], India\u2019s drug manufacturing ecosystem has become eminent to both domestic healthcare and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/\" \/>\n<meta property=\"og:site_name\" content=\"YNZ Group\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-05T07:35:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2025\/11\/Bitter-Dose-for-Pharma-Compliance.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"619\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/\",\"url\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/\",\"name\":\"A Bitter Dose for Pharma Compliance - YNZ Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Bitter-Dose-for-Pharma-Compliance.jpg\",\"datePublished\":\"2025-11-22T07:00:09+00:00\",\"dateModified\":\"2026-11-05T07:35:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Bitter-Dose-for-Pharma-Compliance.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Bitter-Dose-for-Pharma-Compliance.jpg\",\"width\":619,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/wednesday-wisdom-articles\\\/other\\\/a-bitter-dose-for-pharma-compliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wednesday Wisdom\",\"item\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wednesday-wisdom-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A Bitter Dose for Pharma Compliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/\",\"name\":\"YNZ Group\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#organization\",\"name\":\"YNZ Group\",\"url\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/YNZ-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/YNZ-logo.png\",\"width\":1612,\"height\":568,\"caption\":\"YNZ Group\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ynzgroup.co.in\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Bitter Dose for Pharma Compliance - YNZ Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/","og_locale":"en_US","og_type":"article","og_title":"A Bitter Dose for Pharma Compliance - YNZ Group","og_description":"Introduction[1]: India, now also referred to as the \u201cPharmacy of the World,\u201d has emerged as a global pharmaceutical powerhouse supplying to global vaccine demand and exporting affordable generic medicines to several countries. With an industry valued at over USD 49.78 billion in 2023[2], India\u2019s drug manufacturing ecosystem has become eminent to both domestic healthcare and [&hellip;]","og_url":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/","og_site_name":"YNZ Group","article_modified_time":"2026-11-05T07:35:58+00:00","og_image":[{"width":619,"height":600,"url":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2025\/11\/Bitter-Dose-for-Pharma-Compliance.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/","url":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/","name":"A Bitter Dose for Pharma Compliance - YNZ Group","isPartOf":{"@id":"https:\/\/www.ynzgroup.co.in\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/#primaryimage"},"image":{"@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2025\/11\/Bitter-Dose-for-Pharma-Compliance.jpg","datePublished":"2025-11-22T07:00:09+00:00","dateModified":"2026-11-05T07:35:58+00:00","breadcrumb":{"@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/#primaryimage","url":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2025\/11\/Bitter-Dose-for-Pharma-Compliance.jpg","contentUrl":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2025\/11\/Bitter-Dose-for-Pharma-Compliance.jpg","width":619,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.ynzgroup.co.in\/wednesday-wisdom-articles\/other\/a-bitter-dose-for-pharma-compliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ynzgroup.co.in\/blog\/"},{"@type":"ListItem","position":2,"name":"Wednesday Wisdom","item":"https:\/\/www.ynzgroup.co.in\/blog\/wednesday-wisdom-articles\/"},{"@type":"ListItem","position":3,"name":"A Bitter Dose for Pharma Compliance"}]},{"@type":"WebSite","@id":"https:\/\/www.ynzgroup.co.in\/blog\/#website","url":"https:\/\/www.ynzgroup.co.in\/blog\/","name":"YNZ Group","description":"","publisher":{"@id":"https:\/\/www.ynzgroup.co.in\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ynzgroup.co.in\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ynzgroup.co.in\/blog\/#organization","name":"YNZ Group","url":"https:\/\/www.ynzgroup.co.in\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ynzgroup.co.in\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2026\/01\/YNZ-logo.png","contentUrl":"https:\/\/www.ynzgroup.co.in\/blog\/wp-content\/uploads\/2026\/01\/YNZ-logo.png","width":1612,"height":568,"caption":"YNZ Group"},"image":{"@id":"https:\/\/www.ynzgroup.co.in\/blog\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/wednesday_wisdom\/1920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/wednesday_wisdom"}],"about":[{"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/types\/wednesday_wisdom"}],"version-history":[{"count":4,"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/wednesday_wisdom\/1920\/revisions"}],"predecessor-version":[{"id":1925,"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/wednesday_wisdom\/1920\/revisions\/1925"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/media\/1922"}],"wp:attachment":[{"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/media?parent=1920"}],"wp:term":[{"taxonomy":"practice_area","embeddable":true,"href":"https:\/\/www.ynzgroup.co.in\/blog\/wp-json\/wp\/v2\/practice_area?post=1920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}